Dominick V Sinicropi is a notable inventor based in the United States. He has made significant contributions to the field of breast cancer research. His work focuses on developing methods to predict breast cancer prognosis, which is crucial for improving patient outcomes.

Latest Patents

Dominick V Sinicropi holds a patent titled "Method Of Predicting Breast Cancer Prognosis." This invention relates to biomarkers associated with breast cancer prognosis. These biomarkers include coding transcripts and their expression products, as well as non-coding transcripts. They are useful for predicting the likelihood of breast cancer recurrence in patients. The invention also introduces a novel method for identifying intergenic sequences that correlate with clinical outcomes.

Career Highlights

Dominick is currently associated with Genomic Health, Inc., a company dedicated to advancing cancer care through genomic testing. His work at Genomic Health has positioned him as a key player in the field of cancer prognosis.

Collaborations

He has collaborated with notable colleagues, including Joffre B Baker and Robert J Pelham. These collaborations have further enhanced the research and development of innovative solutions in cancer prognosis.

Conclusion

Dominick V Sinicropi's contributions to breast cancer prognosis through his innovative methods and collaborations highlight his commitment to improving patient care. His work continues to influence the field of oncology and offers hope for better outcomes in breast cancer treatment.

Profile summary based on public USPTO records.